Thyroid Ophthalmopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-02-23
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease [Phase 2, Phase 3]
A study evaluating the efficacy and safety of HBM9161 on moderate to severe thyroid eye disease (thyroid ophthalmopathy) in Phase 2 and Phas…